Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Review of Integrated Mental Health and Substance Abuse Treatment for Patients With Dual Disorders

Review of Integrated Mental Health and Substance Abuse Treatment for Patients With Dual Disorders Patients with severe mental disorders such as schizophrenia and co-occurring substance use disorders traditionally received treatments for their two disorders from two different sets of clinicians in parallel treatment systems. Dissatisfaction with this clinical tradition led to the development of integrated treatment models in which the same clinicians or teams of clinicians provide substance abuse treatment and mental health treatment in a coordinated fashion. We reviewed 36 research studies on the effectiveness of integrated treatment for dually diagnosed patients. Studies of adding dual-disorders groups to traditional services, studies of intensive integrated treatments in controlled settings, and studies of demonstration projects have thus far yielded disappointing results. On the other hand, 10 recent studies of comprehensive, integrated outpatient treatment programs provide encouraging evidence of the programs' potential to engage dually diagnosed patients in services and to help them reduce substance abuse and attain remission. Outcomes related to hospital use, psychiatric symptoms, and other domains are less consistent. Several program features appear to be associated with effectiveness: assertive outreach, case management, and a longitudinal, stage-wise, motivational approach to substance abuse treatment. Given the magnitude and severity of the problem of dual disorders, more controlled research on integrated treatment is needed. Key words Substance abuse dual disorders integrated treatment case management dual diagnosis © Oxford University Press « Previous | Next Article » Table of Contents This Article Schizophr Bull (1998) 24 (4): 589-608. » Abstract Free Full Text (PDF) Free Classifications Articles Services Article metrics Alert me when cited Alert me if corrected Find similar articles Similar articles in Web of Science Similar articles in PubMed Add to my archive Download citation Request Permissions Citing Articles Load citing article information Citing articles via CrossRef Citing articles via Scopus Citing articles via Web of Science Citing articles via Google Scholar Google Scholar Articles by Drake, R. E. Articles by Bond, G. R. Search for related content PubMed PubMed citation Articles by Drake, R. E. Articles by Mercer-McFadden, C. Articles by Mueser, K. T. Articles by McHugo, G. J. Articles by Bond, G. R. Related Content Load related web page information Share Email this article CiteULike Delicious Facebook Google+ Mendeley Twitter What's this? Search this journal: Advanced » Current Issue November 2015 41 (6) Alert me to new issues The Journal About this journal Announcements Rights & Permissions The Bulletin in the News Dispatch date of the next issue We are mobile – find out more In Memoriam - Dr Wayne S. Fenton MD Journals Career Network Published in association with An Official Journal of the Schizophrenia International Research Society Impact factor: 8.450 5-Yr impact factor: 8.686 Editor-in-Chief William T. Carpenter View full editorial board For Authors Instructions to authors Online submission Self-archiving policy Submit a manuscript Open access options for authors - visit Oxford Open Alerting Services Email table of contents Email Advance Access CiteTrack XML RSS feed Corporate Services Advertising sales Reprints Supplements Classified Advertising var taxonomies = ("MED00810"); Most Most Read Effects of Toxoplasma on Human Behavior The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia Measuring Mental Illness Stigma The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway Recovery From Schizophrenia: With Views of Psychiatrists, Psychologists, and Others Diagnosed With This Disorder » View all Most Read articles Most Cited The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia Neurocognitive Deficits and Functional Outcome in Schizophrenia: Are We Measuring the "Right Stuff"? The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway The Quality of Life Scale: An Instrument for Rating the Schizophrenic Deficit Syndrome The Functional Significance of Social Cognition in Schizophrenia: A Review » View all Most Cited articles Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department. Online ISSN 1745-1701 - Print ISSN 0586-7614 Copyright © 2015 Maryland Psychiatric Research Center and Oxford University Press Oxford Journals Oxford University Press Site Map Privacy Policy Cookie Policy Legal Notices Frequently Asked Questions Other Oxford University Press sites: Oxford University Press Oxford Journals China Oxford Journals Japan Academic & Professional books Children's & Schools Books Dictionaries & Reference Dictionary of National Biography Digital Reference English Language Teaching Higher Education Textbooks International Education Unit Law Medicine Music Online Products & Publishing Oxford Bibliographies Online Oxford Dictionaries Online Oxford English Dictionary Oxford Language Dictionaries Online Oxford Scholarship Online Reference Rights and Permissions Resources for Retailers & Wholesalers Resources for the Healthcare Industry Very Short Introductions World's Classics function fnc_onDomLoaded() { var query_context = getQueryContext(); PF_initOIUnderbar(query_context,":QS:default","","JRN"); PF_insertOIUnderbar(0); }; if (window.addEventListener) { window.addEventListener('load', fnc_onDomLoaded, false); } else if (window.attachEvent) { window.attachEvent('onload', fnc_onDomLoaded); } var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www."); document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E")); try { var pageTracker = _gat._getTracker("UA-189672-16"); pageTracker._setDomainName(".oxfordjournals.org"); pageTracker._trackPageview(); } catch(err) {} http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Schizophrenia Bulletin Oxford University Press

Review of Integrated Mental Health and Substance Abuse Treatment for Patients With Dual Disorders

Loading next page...
 
/lp/oxford-university-press/review-of-integrated-mental-health-and-substance-abuse-treatment-for-pZAeKS9iW1

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Oxford University Press
Copyright
Copyright © 2015 Maryland Psychiatric Research Center and Oxford University Press
ISSN
0586-7614
eISSN
1745-1701
DOI
schizophreniabulletin;24/4/589
Publisher site
See Article on Publisher Site

Abstract

Patients with severe mental disorders such as schizophrenia and co-occurring substance use disorders traditionally received treatments for their two disorders from two different sets of clinicians in parallel treatment systems. Dissatisfaction with this clinical tradition led to the development of integrated treatment models in which the same clinicians or teams of clinicians provide substance abuse treatment and mental health treatment in a coordinated fashion. We reviewed 36 research studies on the effectiveness of integrated treatment for dually diagnosed patients. Studies of adding dual-disorders groups to traditional services, studies of intensive integrated treatments in controlled settings, and studies of demonstration projects have thus far yielded disappointing results. On the other hand, 10 recent studies of comprehensive, integrated outpatient treatment programs provide encouraging evidence of the programs' potential to engage dually diagnosed patients in services and to help them reduce substance abuse and attain remission. Outcomes related to hospital use, psychiatric symptoms, and other domains are less consistent. Several program features appear to be associated with effectiveness: assertive outreach, case management, and a longitudinal, stage-wise, motivational approach to substance abuse treatment. Given the magnitude and severity of the problem of dual disorders, more controlled research on integrated treatment is needed. Key words Substance abuse dual disorders integrated treatment case management dual diagnosis © Oxford University Press « Previous | Next Article » Table of Contents This Article Schizophr Bull (1998) 24 (4): 589-608. » Abstract Free Full Text (PDF) Free Classifications Articles Services Article metrics Alert me when cited Alert me if corrected Find similar articles Similar articles in Web of Science Similar articles in PubMed Add to my archive Download citation Request Permissions Citing Articles Load citing article information Citing articles via CrossRef Citing articles via Scopus Citing articles via Web of Science Citing articles via Google Scholar Google Scholar Articles by Drake, R. E. Articles by Bond, G. R. Search for related content PubMed PubMed citation Articles by Drake, R. E. Articles by Mercer-McFadden, C. Articles by Mueser, K. T. Articles by McHugo, G. J. Articles by Bond, G. R. Related Content Load related web page information Share Email this article CiteULike Delicious Facebook Google+ Mendeley Twitter What's this? Search this journal: Advanced » Current Issue November 2015 41 (6) Alert me to new issues The Journal About this journal Announcements Rights & Permissions The Bulletin in the News Dispatch date of the next issue We are mobile – find out more In Memoriam - Dr Wayne S. Fenton MD Journals Career Network Published in association with An Official Journal of the Schizophrenia International Research Society Impact factor: 8.450 5-Yr impact factor: 8.686 Editor-in-Chief William T. Carpenter View full editorial board For Authors Instructions to authors Online submission Self-archiving policy Submit a manuscript Open access options for authors - visit Oxford Open Alerting Services Email table of contents Email Advance Access CiteTrack XML RSS feed Corporate Services Advertising sales Reprints Supplements Classified Advertising var taxonomies = ("MED00810"); Most Most Read Effects of Toxoplasma on Human Behavior The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia Measuring Mental Illness Stigma The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway Recovery From Schizophrenia: With Views of Psychiatrists, Psychologists, and Others Diagnosed With This Disorder » View all Most Read articles Most Cited The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia Neurocognitive Deficits and Functional Outcome in Schizophrenia: Are We Measuring the "Right Stuff"? The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway The Quality of Life Scale: An Instrument for Rating the Schizophrenic Deficit Syndrome The Functional Significance of Social Cognition in Schizophrenia: A Review » View all Most Cited articles Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department. Online ISSN 1745-1701 - Print ISSN 0586-7614 Copyright © 2015 Maryland Psychiatric Research Center and Oxford University Press Oxford Journals Oxford University Press Site Map Privacy Policy Cookie Policy Legal Notices Frequently Asked Questions Other Oxford University Press sites: Oxford University Press Oxford Journals China Oxford Journals Japan Academic & Professional books Children's & Schools Books Dictionaries & Reference Dictionary of National Biography Digital Reference English Language Teaching Higher Education Textbooks International Education Unit Law Medicine Music Online Products & Publishing Oxford Bibliographies Online Oxford Dictionaries Online Oxford English Dictionary Oxford Language Dictionaries Online Oxford Scholarship Online Reference Rights and Permissions Resources for Retailers & Wholesalers Resources for the Healthcare Industry Very Short Introductions World's Classics function fnc_onDomLoaded() { var query_context = getQueryContext(); PF_initOIUnderbar(query_context,":QS:default","","JRN"); PF_insertOIUnderbar(0); }; if (window.addEventListener) { window.addEventListener('load', fnc_onDomLoaded, false); } else if (window.attachEvent) { window.attachEvent('onload', fnc_onDomLoaded); } var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www."); document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E")); try { var pageTracker = _gat._getTracker("UA-189672-16"); pageTracker._setDomainName(".oxfordjournals.org"); pageTracker._trackPageview(); } catch(err) {}

Journal

Schizophrenia BulletinOxford University Press

Published: Jan 1, 1998

There are no references for this article.